Fideuram Intesa Sanpaolo Private Banking S.P.A. Cuts Stock Position in Colgate-Palmolive Company $CL

Fideuram Intesa Sanpaolo Private Banking S.P.A. cut its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 13.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 159,969 shares of the company’s stock after selling 24,800 shares during the quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A.’s holdings in Colgate-Palmolive were worth $13,634,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Patten Group Inc. grew its position in shares of Colgate-Palmolive by 1.4% during the first quarter. Patten Group Inc. now owns 13,808 shares of the company’s stock worth $1,177,000 after purchasing an additional 194 shares in the last quarter. KPP Advisory Services LLC lifted its holdings in Colgate-Palmolive by 4.9% in the 1st quarter. KPP Advisory Services LLC now owns 10,227 shares of the company’s stock worth $872,000 after purchasing an additional 478 shares in the last quarter. Capital Asset Advisory Services LLC boosted its stake in Colgate-Palmolive by 2.6% in the 1st quarter. Capital Asset Advisory Services LLC now owns 26,404 shares of the company’s stock worth $2,205,000 after purchasing an additional 676 shares during the period. Fulton Bank N.A. boosted its stake in Colgate-Palmolive by 15.5% in the 1st quarter. Fulton Bank N.A. now owns 9,136 shares of the company’s stock worth $779,000 after purchasing an additional 1,223 shares during the period. Finally, USS Investment Management Ltd grew its holdings in Colgate-Palmolive by 2.5% during the 1st quarter. USS Investment Management Ltd now owns 2,200,744 shares of the company’s stock valued at $187,536,000 after buying an additional 54,122 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL opened at $95.17 on Friday. The firm has a fifty day simple moving average of $88.81 and a two-hundred day simple moving average of $87.56. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. The stock has a market capitalization of $76.15 billion, a P/E ratio of 37.03, a PEG ratio of 4.89 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The company’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same period last year, the company earned $0.91 EPS. On average, analysts expect that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be given a $0.53 dividend. The ex-dividend date is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.2%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 82.49%.

Wall Street Analysts Forecast Growth

CL has been the topic of several research analyst reports. UBS Group boosted their target price on shares of Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, May 4th. The Goldman Sachs Group reiterated a “buy” rating on shares of Colgate-Palmolive in a report on Friday, May 1st. Bank of America decreased their price target on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research note on Friday, April 10th. Weiss Ratings raised shares of Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Finally, Piper Sandler cut their price objective on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Twelve research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.